Seeking A Cure for a RARE AND DEADLY pediatric Bone Cancer In June of 2015, weeks after his graduation, cum laude, from Centenary College in New Jersey, Matthew Adam Lehrman was diagnosed with stage 4 metastatic osteosarcoma. For two years, Matthew fought the rare childhood bone cancer, all the while remaining cheerful and determined to beat the disease. From hospital beds around the country, Matthew enthusiastically raised money for the patient-based charity MIB Agents. Matthew lost his battle on May 3, 2017. With less than 400 new diagnoses annually in the United States, osteosarcoma is a rare pediatric cancer that is grossly underfunded. The Matthew Lehrman Osteosarcoma Fund was formed to continue Matthew’s mission to increase awareness of the disease, raise money for research and to advocate for patients and their families.